Medical Customer News Details

LABORIE has completed its acquisition of Medical Measurement Systems (“MMS”). MMS is headquartered in Enschede, The Netherlands with a German subsidiary in Bottrop and US operations in Dover, New Hampshire. MMS is a global market leader in Gastrointestinal Diagnostics and Urodynamics.

LABORIE’s acquisition of MMS extends its Gastroenterology product offering following its acquisition of Unisensor in October 2014. Additionally, MMS’ Urodynamic product lines complement LABORIE’s Urodynamic product offering and extend its global reach.

“This is a very strategic acquisition for LABORIE,” stated Brian Ellacott, LABORIE President and CEO. “MMS has developed user-friendly products based on a unique platform that simultaneously supports Urology and Gastroenterology customers. We see tremendous opportunities to leverage this single platform across all our products and extend our global reach through the MMS global distribution network. We see this as a very complementary acquisition.”

MMS President, Arjen de Weerd stated, “We are very pleased to be part of the LABORIE team. The combined resources of these two innovative companies, will allow us to develop the “next generation” products our customers are requesting and expand our footprint globally. Both I and co-founder Jan-Willem van der Wal are eager to participate with the LABORIE team in building truly innovative products for the GI and Urology markets.”

About LABORIE

LABORIE (www.laborie.com), headquartered in Toronto, Canada, is a leading global developer, manufacturer and marketer of innovative medical technology and consumables for the diagnosis and treatment of Urinary and Fecal Incontinence, as well as other pelvic floor disorders in the Urology, Gynecology, and Colorectal fields.

Laborie Medical Technologies, Corp

78 Blanchard Road, Suite 404

Burlington

Massachusetts

01803

United States

All Registered Trademarks, brand names and logos are respected and their ownership acknowledged. They are used on this website for information and reference purposes only. Test Interest doesn't assume any other implication or representation.

TI-IND-MED-4-1